Leaflet PIRAZINAMIDA ATB 500mg tablets
Indicated for: tuberculosis
Route of administration: oral
Substance: pyrazinamide (anti-tuberculosis agent)
ATC: J04AK01 (Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Other drugs for treatment of tuberculosis)
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
Periodic laboratory tests may be required during treatment.
Use during pregnancy only on medical advice.
Pyrazinamide is an antitubercular medication used in the treatment of tuberculosis, particularly in the initial phase of combination therapy. It works by inhibiting the synthesis of fatty acids essential for Mycobacterium tuberculosis, contributing to bacterial destruction.
The medication is taken orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor liver function.
Patients should be aware of potential side effects, such as nausea, joint pain, or symptoms of liver damage. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, joint pain, and elevated liver enzymes. In rare cases, severe reactions such as hepatitis or allergic reactions may occur. Patients should be informed of these risks before use.
General data about PIRAZINAMIDA ATB 500mg
- Substance: pyrazinamide
- Date of latest medicines list: 01-06-2026
- Product code: W60213002
- Concentration: 500mg
- Pharmaceutical form: tablets
- Quantity: 1500
- Product type: Generic medicine
- Price: 1037.05 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Compensation lists for PIRAZINAMIDA ATB 500mg Antibiotice
NHP 1.A (C2) - People with HIV/AIDS and post-exposure treatment
Price
Copayment
Patient
1037.05 RON
1037.05 RON
0.00 RON